Moderna aims to price coronavirus vaccine at $50-$60 per course: Report – Hindustan Times
1 min read
Industry analysts said Pfizer and BioNTech’s $2 billion deal to cover 50 million patients, which is contingent on an approvable product, would likely pressure other manufacturers to set similar prices.
Industry analysts said Pfizer and BioNTech’s $2 billion deal to cover 50 million patients, which is contingent on an approvable product, would likely pressure other manufacturers to set similar prices.
Read More
